4/17
12:19 pm
cgon
CG Oncology (CGON) had its price target raised by JPMorgan Chase & Co. from $65.00 to $91.00. They now have an "overweight" rating on the stock.
Medium
Report
CG Oncology (CGON) had its price target raised by JPMorgan Chase & Co. from $65.00 to $91.00. They now have an "overweight" rating on the stock.
4/11
01:00 am
cgon
Low
Report
4/7
08:02 am
cgon
CG Oncology (CGON) had its price target raised by HC Wainwright from $80.00 to $100.00. They now have a "buy" rating on the stock.
Medium
Report
CG Oncology (CGON) had its price target raised by HC Wainwright from $80.00 to $100.00. They now have a "buy" rating on the stock.
4/5
04:57 am
cgon
CG Oncology: Passing A Red Line For What I Would Call A Reasonable Valuation (Rating Downgrade) [Seeking Alpha]
Low
Report
CG Oncology: Passing A Red Line For What I Would Call A Reasonable Valuation (Rating Downgrade) [Seeking Alpha]
3/28
01:05 am
cgon
Low
Report
3/21
06:34 pm
cgon
This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know [Yahoo! Finance]
Low
Report
This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know [Yahoo! Finance]
3/14
09:51 pm
cgon
Is CG Oncology (CGON) Pricing Reflect Its Recent 131% Surge And Cancer Breakthrough Hopes [Yahoo! Finance]
Low
Report
Is CG Oncology (CGON) Pricing Reflect Its Recent 131% Surge And Cancer Breakthrough Hopes [Yahoo! Finance]
3/8
03:15 am
cgon
CG Oncology Conference: Credo Posts 75.5% CR in BOND-003, BLA Filing Targeted for 2026 [Yahoo! Finance]
Low
Report
CG Oncology Conference: Credo Posts 75.5% CR in BOND-003, BLA Filing Targeted for 2026 [Yahoo! Finance]
3/6
10:36 am
cgon
H.C. Wainwright Raises its Price Target on CG Oncology, Inc. (CGON) to $80 and Maintains a Buy Rating [Yahoo! Finance]
Low
Report
H.C. Wainwright Raises its Price Target on CG Oncology, Inc. (CGON) to $80 and Maintains a Buy Rating [Yahoo! Finance]
2/27
02:38 pm
cgon
CG Oncology GAAP EPS of -$2.08 beats by $0.09, revenue of $4.04M beats by $1.24M [Seeking Alpha]
Neutral
Report
CG Oncology GAAP EPS of -$2.08 beats by $0.09, revenue of $4.04M beats by $1.24M [Seeking Alpha]
2/27
02:22 pm
cgon
CG Oncology (CGON) had its price target raised by HC Wainwright from $75.00 to $80.00. They now have a "buy" rating on the stock.
Low
Report
CG Oncology (CGON) had its price target raised by HC Wainwright from $75.00 to $80.00. They now have a "buy" rating on the stock.
2/27
08:50 am
cgon
CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates [Yahoo! Finance]
Medium
Report
CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates [Yahoo! Finance]
2/27
08:30 am
cgon
CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates
Medium
Report
CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates
2/23
08:25 am
cgon
CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Low
Report
CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
2/23
08:00 am
cgon
CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference
Low
Report
CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference
2/22
11:50 pm
cgon
Assessing CG Oncology (CGON) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
Low
Report
Assessing CG Oncology (CGON) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
2/10
08:05 am
cgon
CG Oncology (NASDAQ:CGON) had its price target raised by analysts at Truist Financial Corporation from $66.00 to $75.00. They now have a "buy" rating on the stock.
Medium
Report
CG Oncology (NASDAQ:CGON) had its price target raised by analysts at Truist Financial Corporation from $66.00 to $75.00. They now have a "buy" rating on the stock.
1/21
07:17 am
cgon
CG Oncology (NASDAQ:CGON) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Medium
Report
CG Oncology (NASDAQ:CGON) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.